CNBC Investing Club

Investing Club: We're capitalizing on one of our drug stocks' incredible run, selling some shares

Traders work on the floor of the New York Stock Exchange.
NYSE

We're selling 200 shares of Abbvie (ABBV) at roughly $147.65. Following the trade, we'll own 700 shares of ABBV, decreasing its weighting to 2.68% from 3.42%.

More In CNBC Investing Club Newsletter

CNBC Investing Club3 takeaways from the Investing Club’s ‘Morning Meeting’ on Monday
3 hours ago
CNBC Investing ClubNvidia resets expectations with warning of quarterly miss due to gaming weakness
4 hours ago
CNBC Investing ClubWhat Cramer is watching Monday — IRA lifts EV and solar stocks, Pfizer's buy
4 hours ago